Navigation Links
NJIT author to speak at UNC about hemophilia
Date:3/26/2012

NJIT Associate Professor Stephen Pemberton has been invited to speak at the Bullitt History of Medicine Club at the University of North Carolina (UNC) about how hemophilia became manageable in the 20th century. Pemberton is the author of The Bleeding Disease: Hemophilia and the Unintended Consequences of Medical Progress (Johns Hopkins University Press, 2011). He is also an expert on hemophilia and the medical developments of the 20th-century that transformed the illness from an obscure hereditary malady into a manageable bleeding disorder. He teaches in the Federated Dept. of History at NJIT and Rutgers-Newark.

The talk, set for tomorrow at 5:30 p.m. in the UNC Health Science Library (Room 527), is free and open to the public. To attend, call 919-962-0500 or visit the Bullitt History of Medicine Club, http://www.med.unc.edu/bhomc/.

Pemberton's lecture will focus on pioneering medicine at UNC and highlight early research into hemophilia there. Eventually this work led to the establishment of the UNC Hemophilia and Thrombosis Center, recognized by the World Federation of Hemophilia as an International Hemophilia Training Center. In addition to Pemberton's continued research on the problems associated with the historical management of chronic diseases, he is investigating the role of hematologists in the development of modem genetic medicine. He is interested in the cultural, social and health implications of blood as a commodity.

Pemberton was co-recipient of the 2006 Association of American Publishers/Professional and Scholarly Publishing Division book award in the history of science category. He received an M.A. in Philosophy from the University of Memphis and an M.A. & Ph.D. in the History of Science University of North Carolina at Chapel Hill.


'/>"/>

Contact: Sheryl Weinstein
973-596-3436
New Jersey Institute of Technology
Source:Eurekalert

Page: 1

Related medicine news :

1. Aging authorities differ on tweaks to Social Securitys benefit structure
2. Academics guest authoring ghostwritten medical journal articles should be charged with fraud
3. UDs Roberta Colman ranks in top 50 most prolific authors in Biochemistry
4. Controversial TOFT theory of cancer versus SMT model: Authors do battle in BioEssays
5. OHSU expert co-authors study finding treatment for rare lung disease
6. Boston University School of Medicine professor co-authors first book on deaf ethnicity
7. Women and Infants physician authors chapter in reference book
8. Author who revealed unethical Guatemala syphilis study writes for Bioethics Forum
9. Medical Study Authors Often Fail to Disclose Industry Ties
10. UNC physician authors editorial on cost-effectiveness study for colon cancer screening
11. Self-Published Author Shares Her Personal Story of Hope Amidst Despair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... At Hallmark Nameplate, their commitment ... they have achieved certification to ISO 13485. This certification is another way they are ... date products and services that they need. , The ISO 13485 Certification is a ...
(Date:1/18/2017)... NJ (PRWEB) , ... January 18, 2017 , ... ... care communications company, launched a new website for its Center for Biosimilars, announced ... will include the latest developments in the field of biosimilars through thought leader ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... gum disease to enamel erosion, and those dental problems can increase the risk ... Health, many pregnant women are failing to get the dental care they need. ...
(Date:1/17/2017)... ... January 17, 2017 , ... Anesthesia Progress ... dentists to choose the best drug option for each patient. Dentists have several general ... better overall outcomes. , Researchers from the Tokyo Dental College in Tokyo, Japan wanted ...
(Date:1/17/2017)... ... , ... For breast cancer clinicians and researchers who were unable to attend ... intimate review and analysis of its highlights, a novel half-day, complimentary meeting—the 14th Annual ... on February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, FACP, FASCO ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... Iowa , Jan. 18, 2017   ... that subsidiary Caretta Therapeutics plans, in the second ... Venodol, a topical roll-on intended to provide relief ... opioid and steroidal analgesics. It was developed under ... to commercialize products derived from snake venom. ...
(Date:1/18/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, announces dosing the first patient ... 2 acne rosacea study. DMT210 is a topical ... in the skin responsible for the inflammation and ... This clinical trial, DMT210-003, is a 12-week, Phase ...
(Date:1/18/2017)... Jan. 17, 2017  With an annual growth ranging from 6% to 10%, ... SEA (Jakarta International Expo, March 22-24, 2017) serves the industry by fostering the ... CPhI SEA 2017? Investment Forum ASEAN -- ... Richer conference content Enhanced business matchmaking program ... ...
Breaking Medicine Technology: